Curasept

Abion Assists Curasept in Strategic Partnership with Laboratorios Normon for the Spanish Market

Expanding into new international markets presents both opportunities and challenges for growing brands. While it offers access to new customers and strengthens global recognition, it also demands careful navigation of local regulations, commercial partnerships, and intellectual property frameworks. For companies in the health and life sciences sector, these complexities are further magnified by stringent compliance requirements and the need to maintain brand integrity across diverse jurisdictions.

Curasept, a leading Italian innovator in oral health, faced precisely these challenges when preparing its entry into the Spanish market. To support this strategic step, the company turned to Abion, and in particular, to Attorney and Legal Director Eleonora Ortaglio, for high-level guidance in designing and securing a partnership model capable of sustaining long-term international growth.

CHALLENGE

Navigating Market Entry Complexity

Curasept identified Spain as a priority within its European expansion strategy, requiring a local partner capable of strengthening distribution and boosting market penetration.

But entering the Iberian market also meant addressing a number of legal and operational complexities, including regulatory requirements, brand positioning, licensing, co-branding, and the protection of proprietary technologies.

The company needed a partnership structure that balanced commercial opportunity with strong legal safeguards. It required a legal advisor capable not only of drafting agreements but also of shaping a strategic, cross-border framework aligned with Curasept’s long-term vision.

SOLUTION

Strategic Legal Framework for Growth

Under the leadership of Eleonora Ortaglio, Abion played an instrumental role in structuring and negotiating the partnership with Laboratorios Normon, one of the most respected pharmaceutical companies in Spain.

Litigation & ADR: Protecting Your Rights
Eleonora personally led the legal strategy for the entire operation, working closely with Curasept’s International Business Development team to create a partnership framework grounded in legal precision, business pragmatism, and long-term scalability.

Her contribution helped to:

• Negotiate the full contractual architecture of the collaboration, from distribution terms to governance and performance obligations.
• Define co-branding rules and brand-protection mechanisms, ensuring consistent market positioning of the Bucomed PRO by Curasept Afterapid+ line.
• Design a robust IP protection strategy, covering trademarks, proprietary technologies, compliance standards, and usage limitations.
• Align the agreement with EU and Spanish regulatory requirements, guaranteeing a smooth market entry with no operational friction.

RESULT

A Strong Launch in the Spanish Market

The partnership between Curasept and Laboratorios Normon marks a significant milestone in Curasept’s international journey. The successful launch of Bucomed PRO by Curasept Afterapid+ in the Spanish market demonstrates the effectiveness of a well-structured legal and commercial collaboration.

Through Abion’s strategic support, Curasept has secured a strong and sustainable presence in the Iberian market, reinforcing its reputation as an innovative and globally minded oral health brand. The project also highlights Abion’s ability to guide clients through complex international negotiations, combining legal precision with business insight to achieve lasting impact.